Comparative genomics of quinolone-resistant Escherichia coli from broilers and humans in Norway
-
Published:2024-07-06
Issue:1
Volume:24
Page:
-
ISSN:1471-2180
-
Container-title:BMC Microbiology
-
language:en
-
Short-container-title:BMC Microbiol
Author:
Slettemeås Jannice Schau,Sekse Camilla,Sunde Marianne,Norström Madelaine,Wester Astrid Louise,Naseer Umaer,Simonsen Gunnar Skov,Ulstad Charlotte Rosenberg,Urdahl Anne Margrete,Lagesen Karin
Abstract
Abstract
Background
The usage of fluoroquinolones in Norwegian livestock production is very low, including in broiler production. Historically, quinolone-resistant Escherichia coli (QREC) isolated from Norwegian production animals rarely occur. However, with the introduction of a selective screening method for QREC in the Norwegian monitoring programme for antimicrobial resistance in the veterinary sector in 2014; 89.5% of broiler caecal samples and 70.7% of broiler meat samples were positive. This triggered the concern if there could be possible links between broiler and human reservoirs of QREC. We are addressing this by characterizing genomes of QREC from humans (healthy carriers and patients) and broiler isolates (meat and caecum).
Results
The most frequent mechanism for quinolone resistance in both broiler and human E. coli isolates were mutations in the chromosomally located gyrA and parC genes, although plasmid mediated quinolone resistance (PMQR) was also identified. There was some relatedness of the isolates within human and broiler groups, but little between these two groups. Further, some overlap was seen for isolates with the same sequence type isolated from broiler and humans, but overall, the SNP distance was high.
Conclusion
Based on data from this study, QREC from broiler makes a limited contribution to the incidence of QREC in humans in Norway.
Funder
Norwegian Research Funding for Agriculture and Food Industry
Norwegian Veterinary Institute
Publisher
Springer Science and Business Media LLC
Reference85 articles.
1. Bolon MK. The newer fluoroquinolones. Med Clin North Am. 2011;95(4):793–817. viii.
2. NORM/NORM-VET. NORM/NORM-VET. 2022. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø / Oslo; 2023. Report No.: ISSN:1502–2307 (print) / 1890–9965 (electronic).
3. Norwegian Directory of Health. Antibiotics in primary care 2024 [ https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-primaerhelsetjenesten
4. Norwegian Directory of Health. Antibiotics in the hospital 2024 [ https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus
5. WHO. Critically important antimicrobials for human medicine, 6th revision. Licence: CC BY-NC-SA 3.0 IGO. World Health Organization; 2019.